Literature DB >> 2834947

Human parvovirus B19-induced vesiculopustular skin eruption.

S J Naides1, W Piette, L A Veach, Z Argenyi.   

Abstract

Erythema infectiosum, fifth disease, is a usually benign macular or maculopapular exanthem of childhood caused by the human parvovirus B19. A 27-year-old woman with a serologically documented human parvovirus infection who presented with a hemorrhagic exanthem and enanthem with areas of pustules and pseudo-pustules is described. The histologic findings were unusual because they combined the histologic features of morbilliform and vesiculopustular viral lesions. This case serves to underscore the occurrence of human parvovirus infection in adults. Further, it demonstrates the need to include parvovirus infection in the differential diagnosis of virally induced vesiculopustular skin eruptions.

Entities:  

Mesh:

Year:  1988        PMID: 2834947     DOI: 10.1016/0002-9343(88)90081-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

Review 2.  Erythema infectiosum and pregnancy-related complications.

Authors:  M Levy; S E Read
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Acute Generalized Exanthematous Pustulosis Induced by Cefepime: A Case Report.

Authors:  L F F Botelho; F R Picosse; M H Padilha; N Michalany; A Góis; A M Porro
Journal:  Case Rep Dermatol       Date:  2010-06-01

5.  Infection with Parvovirus B19.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.663

6.  Acute generalized exanthematous pustulosis due to oral use of blue dyes.

Authors:  Osman Sener; Ösman Kose; Özgür Kartal; Mukerrem Safali
Journal:  Korean J Intern Med       Date:  2011-09-13       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.